Advertisement.

INRLF Projected Dividend Yield

Ord/Valneva SE ( OTCBB : INRLF )

Valneva is a vaccine biotech company encompassing research & development, manufacturing and commercialization to develop vaccines. Co.'s products include IXIARO® and JESPECT® that address Japanese encephalitis diseases. Co.'s other product is DUKORAL® a vaccine for cholera and Enterotoxigenic Escherichia coli bacterium. Co. is concentrating its research & development on the development of VLA15 vaccine against Lyme disease, which is a systemic infection caused by Borrelia bacteria transmitted to humans by infected Ixodes ticks. Co. is also progressing on its clinical development of Chikungunya vaccine VLA1553. Co.'s other vaccines in clinical development is Zika vaccine VLA1601.

20 YEAR PERFORMANCE RESULTS

INRLF Dividend History Detail
INRLF Dividend News
INRLF Competitors News

# of Shares: 0

Closing Price: 1.98

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000